VANCOUVER, British Columbia – TheNewswire - October 31, 2023 – Treatment.com International Inc. (CSE:TRUE) (OTC:TREIF) (Frankfurt:939) (the “Company” or “Treatment”) is pleased to announce that the Company’s Board of Directors have approved a name change to “Treatment.com AI Inc.”  The Company’s trading symbol on the Canadian Securities Exchange (“CSE”) shall remain the same.

No action is required to be taken by shareholders with respect to the name change. Outstanding share and warrant certificates are not affected by the name change and do not need to be exchanged. The Company will issue a further news release announcing the effective date in which the Company will commence trading under the new name and CUSIP number.

The name change remains subject to CSE approval.  

Additionally, the Company announces the appointment of Dr. Kevin Peterson, MD as Chief Medical Officer, effective immediately.  

FOR ADDITIONAL INFORMATION, CONTACT: 

Dr. Essam Hamza, CEO

ehamza@treatment.com

(612) 788-8900 

Cautionary Statements

This news release contains forward-looking statements that are based on Treatment.com’s expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to the implementation of its shareholder communications initiative and the timing thereof. Although Treatment.com believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and Treatment.com undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances, unless otherwise required to do so by law. 

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.